AIM2 and arthritic joint disease: With increasing age, signs of chronic polyarthritis progressed to a score of up to 3.4 in the Aim2+/+x Dnase2-/- cohort at 15 months, whereas Aim2-/-x Dnase2-/- mice showed greatly reduced signs of arthritis (mean score of 0.5).